BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 38734765)

  • 1. Hematological and renal toxicity in mice after three cycles of high activity [
    Kristiansson A; Vilhelmsson Timmermand O; Altai M; Strand SE; Åkerström B; Örbom A
    Sci Rep; 2024 May; 14(1):10787. PubMed ID: 38734765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and Multiorgan Safety of
    Herrmann K; Rahbar K; Eiber M; Sparks R; Baca N; Krause BJ; Lassmann M; Jentzen W; Tang J; Chicco D; Klein P; Blumenstein L; Basque JR; Kurth J
    J Nucl Med; 2024 Jan; 65(1):71-78. PubMed ID: 38050121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant α
    Alattar AG; Kristiansson A; Karlsson H; Vallius S; Ahlstedt J; Forssell-Aronsson E; Åkerström B; Strand SE; Flygare J; Gram M
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371508
    [No Abstract]   [Full Text] [Related]  

  • 4. GCP III is not the "off-target" for urea-based PSMA ligands.
    Lee Z; Heston WD; Wang X; Basilion JP
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2944-2946. PubMed ID: 37191680
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneity of absorbed dose distribution in kidney tissues and dose-response modelling of nephrotoxicity in radiopharmaceutical therapy with beta-particle emitters: A review.
    Saldarriaga Vargas C; Andersson M; Bouvier-Capely C; Li WB; Madas B; Covens P; Struelens L; Strigari L
    Z Med Phys; 2023 Apr; ():. PubMed ID: 37031068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeutics.
    Lucaroni L; Georgiev T; Prodi E; Puglioli S; Pellegrino C; Favalli N; Prati L; Manz MG; Cazzamalli S; Neri D; Oehler S; Bassi G
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):957-961. PubMed ID: 36184692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive
    Schäfer H; Mayr S; Büttner-Herold M; Knorr K; Steinhelfer L; Böger CA; Gschwend JE; Heemann U; Eiber M; Schmaderer C; Tauber R
    Eur Urol; 2023 May; 83(5):385-390. PubMed ID: 35688660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical investigations using [
    Tschan VJ; Borgna F; Busslinger SD; Stirn M; Rodriguez JMM; Bernhardt P; Schibli R; Müller C
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3639-3650. PubMed ID: 35635566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological Toxicity in Mice after High Activity Injections of
    Kristiansson A; Vilhelmsson Timmermand O; Altai M; Strand J; Strand SE; Åkerström B; Örbom A
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Radiopharmaceutical Therapy on Renal Function.
    Park EA; Graves SA; Menda Y
    Semin Nucl Med; 2022 Jul; 52(4):467-474. PubMed ID: 35314056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns.
    Wahl RL; Sgouros G; Iravani A; Jacene H; Pryma D; Saboury B; Capala J; Graves SA
    J Nucl Med; 2021 Dec; 62(Suppl 3):23S-35S. PubMed ID: 34857619
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney Protection with the Radical Scavenger α
    Kristiansson A; Örbom A; Vilhelmsson Timmermand O; Ahlstedt J; Strand SE; Åkerström B
    Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Study on [
    Harsini S; Fallahi B; Karamzade Ziarati N; Razi A; Amini E; Emami-Ardekani A; Fard-Esfahani A; Kardoust Parizi M; Farzanehfar S; Beiki D
    Asia Ocean J Nucl Med Biol; 2021; 9(2):101-110. PubMed ID: 34250139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [
    Geenen L; Nonnekens J; Konijnenberg M; Baatout S; De Jong M; Aerts A
    Nucl Med Biol; 2021; 102-103():1-11. PubMed ID: 34242948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic safety of
    Groener D; Nguyen CT; Baumgarten J; Bockisch B; Davis K; Happel C; Mader N; Nguyen Ngoc C; Wichert J; Banek S; Mandel P; Chun FKH; Tselis N; Grünwald F; Sabet A
    EJNMMI Res; 2021 Jul; 11(1):61. PubMed ID: 34216290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
    Sartor O; de Bono J; Chi KN; Fizazi K; Herrmann K; Rahbar K; Tagawa ST; Nordquist LT; Vaishampayan N; El-Haddad G; Park CH; Beer TM; Armour A; Pérez-Contreras WJ; DeSilvio M; Kpamegan E; Gericke G; Messmann RA; Morris MJ; Krause BJ;
    N Engl J Med; 2021 Sep; 385(12):1091-1103. PubMed ID: 34161051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, Functions, and Physiological Roles of the Lipocalin α
    Bergwik J; Kristiansson A; Allhorn M; Gram M; Åkerström B
    Front Physiol; 2021; 12():645650. PubMed ID: 33746781
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kristiansson A; Örbom A; Ahlstedt J; Karlsson H; Zedan W; Gram M; Åkerström B; Strand SE; Altai M; Strand J; Vilhelmsson Timmermand O
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33579037
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.